Prime Medicine, Inc. PRME
NASDAQ · United States · Health Technology
$2.98-0.01 (-0.33%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.24 | -0.26 | +6.7% | $1.15M | -48.7% | 0.0%$3.08→$3.08 |
| Q1 2026 | 2026-05-07 | -0.28 | -0.25 | -12.0% | — | — | -5.9%$3.41→$3.21 |
| Q4 2025 | 2026-03-03 | -0.24 | -0.26 | +7.7% | — | — | -11.6%$4.66→$4.12 |
| Q3 2025 | 2025-11-07 | -0.32 | -0.25 | -28.0% | — | — | -15.7%$4.18→$3.53 |
| Q2 2025 | 2025-08-07 | -0.41 | -0.34 | -20.6% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.40 | -0.31 | -29.0% | — | — | — |
| Q4 2024 | 2025-02-28 | -0.31 | -0.31 | 0.0% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.44 | -0.42 | -4.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.